--- title: "Shin-Etsu Chemical Co., Ltd. Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year" type: "News" locale: "en" url: "https://longbridge.com/en/news/274362543.md" description: "Shin-Etsu Chemical Co., Ltd. reported its third-quarter results, missing revenue estimates by 2.1% but beating earnings per share (EPS) expectations by 5.1%. Following the report, shares fell 8.9%. Analysts forecast revenues of JP¥2.71 trillion for 2027, reflecting a 5.5% increase, with EPS expected to grow 13% to JP¥292. The consensus price target remains at JP¥5,582, indicating stable expectations despite a slowdown in revenue growth compared to historical rates. Analysts' views on the stock's future vary, but overall estimates suggest growth in line with industry averages." datetime: "2026-01-30T22:13:08.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/274362543.md) - [en](https://longbridge.com/en/news/274362543.md) - [zh-HK](https://longbridge.com/zh-HK/news/274362543.md) --- # Shin-Etsu Chemical Co., Ltd. Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year Shareholders might have noticed that **Shin-Etsu Chemical Co., Ltd.** (TSE:4063) filed its third-quarter result this time last week. The early response was not positive, with shares down 8.9% to JP¥5,129 in the past week. Shin-Etsu Chemical missed revenue estimates by 2.1%, coming in atJP¥649b, although statutory earnings per share (EPS) of JP¥67.51 beat expectations, coming in 5.1% ahead of analyst estimates. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. TSE:4063 Earnings and Revenue Growth January 30th 2026 Taking into account the latest results, the most recent consensus for Shin-Etsu Chemical from 18 analysts is for revenues of JP¥2.71t in 2027. If met, it would imply a satisfactory 5.5% increase on its revenue over the past 12 months. Statutory earnings per share are predicted to grow 13% to JP¥292. Yet prior to the latest earnings, the analysts had been anticipated revenues of JP¥2.70t and earnings per share (EPS) of JP¥293 in 2027. The consensus analysts don't seem to have seen anything in these results that would have changed their view on the business, given there's been no major change to their estimates. See our latest analysis for Shin-Etsu Chemical The analysts reconfirmed their price target of JP¥5,582, showing that the business is executing well and in line with expectations. That's not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. There are some variant perceptions on Shin-Etsu Chemical, with the most bullish analyst valuing it at JP¥6,300 and the most bearish at JP¥4,600 per share. As you can see, analysts are not all in agreement on the stock's future, but the range of estimates is still reasonably narrow, which could suggest that the outcome is not totally unpredictable. Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. It's pretty clear that there is an expectation that Shin-Etsu Chemical's revenue growth will slow down substantially, with revenues to the end of 2027 expected to display 4.4% growth on an annualised basis. This is compared to a historical growth rate of 9.0% over the past five years. Juxtapose this against the other companies in the industry with analyst coverage, which are forecast to grow their revenues (in aggregate) 4.4% annually. So it's pretty clear that, while Shin-Etsu Chemical's revenue growth is expected to slow, it's expected to grow roughly in line with the industry. ## The Bottom Line The most obvious conclusion is that there's been no major change in the business' prospects in recent times, with the analysts holding their earnings forecasts steady, in line with previous estimates. They also reconfirmed their revenue estimates, with the company predicted to grow at about the same rate as the wider industry. The consensus price target held steady at JP¥5,582, with the latest estimates not enough to have an impact on their price targets. With that in mind, we wouldn't be too quick to come to a conclusion on Shin-Etsu Chemical. Long-term earnings power is much more important than next year's profits. We have estimates - from multiple Shin-Etsu Chemical analysts - going out to 2028, and you can see them free on our platform here. And what about risks? Every company has them, and we've spotted **2 warning signs for Shin-Etsu Chemical** you should know about. ### Related Stocks - [4063.JP](https://longbridge.com/en/quote/4063.JP.md) - [SHECY.US](https://longbridge.com/en/quote/SHECY.US.md) ## Related News & Research - [Key facts: Shin‑Etsu launches ¥5,235 buyback; rare‑earth ops benefit](https://longbridge.com/en/news/287133310.md) - [Revenue Beat: Furuya Metal Co., Ltd. Exceeded Revenue Forecasts By 55% And Analysts Are Updating Their Estimates](https://longbridge.com/en/news/286657567.md) - [Why Japan Communications' (TSE:9424) Shaky Earnings Are Just The Beginning Of Its Problems](https://longbridge.com/en/news/286824720.md) - [A Look At Japan Post Bank (TSE:7182) Valuation After Earnings Jump And New Medium Term Plan](https://longbridge.com/en/news/287030627.md) - [JAC Recruitment (TSE:2124) EPS Jump In Q1 2026 Tests Cautious Market Narratives](https://longbridge.com/en/news/286545331.md)